CAR-T cell exhaustion in B cell lymphoma: Current status, mechanisms, and potential solutions
{{output}}
Chimeric antigen receptor T cell (CAR-T) therapy represents a revolutionary approach in the treatment of refractory or relapsed hematological malignancies including lymphoma. Despite its efficacy, a significant subset of patients experiences disease progressio... ...
